Herbs and dietary supplements for asthma

Clinical Pulmonary Medicine

Volumn 12, Issue 2, 2005, Pages 67-75

  Kemper, Kathi J ^a   Singla, Manav ^a   Gardiner, Paula ^b,c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Alternative medicine; Asthma; Complementary medicine; Dietary supplements; Folk remedies; Herbs

Indexed keywords

ADRENALIN; ANTIINFLAMMATORY AGENT; ASCORBIC ACID; BOSWELLIA SERRATA EXTRACT; BRONCHODILATING AGENT; CAFFEINE; CIMETIDINE; EMOLLIENT AGENT; EPHEDRA EXTRACT; EPHEDRINE; ESTROGEN; FENOTEROL; FISH OIL; FLUVOXAMINE; FORSKOLIN; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; MAGNESIUM; ORAL CONTRACEPTIVE AGENT; PETASITES HYBRIDUS EXTRACT; PLANT EXTRACT; QUINOLONE DERIVATIVE; RESERPINE; SALBUTAMOL; SPASMOLYTIC AGENT; TERBUTALINE; THEOPHYLLINE; TYLOPHOROA ASTHMATICA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL;

ABDOMINAL PAIN; ACUPUNCTURE; ALTERNATIVE MEDICINE; ANXIETY; ASTHMA; BLEEDING; CARCINOGENICITY; COUGHING; DEATH; DIARRHEA; DIET SUPPLEMENTATION; DIURESIS; DIZZINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; EDEMA; EPHEDRA; FATIGUE; FEEDBACK SYSTEM; FLUSHING; GASTROINTESTINAL SYMPTOM; HALITOSIS; HEADACHE; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HEARTBURN; HERB; HERBAL MEDICINE; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPOTENSION; INSOMNIA; IRRITABILITY; LETHARGY; LIVER TOXICITY; MASSAGE; MEDICINAL PLANT; MUCOSA; MUSCLE SPASM; MUSCLE WEAKNESS; MYALGIA; NAUSEA; NEPHROLITHIASIS; NERVOUSNESS; NONHUMAN; OCULAR PRURITUS; PARALYSIS; PRURITUS; REVIEW; RHABDOMYOLYSIS; SEIZURE; SIDE EFFECT; SKIN BRUISING; SLEEP DISORDER; STOMACH DISEASE; STROKE; TACHYCARDIA; TREMOR; URINE RETENTION; VEIN OCCLUSION; VOMITING; WHEEZING; WITHDRAWAL SYNDROME;

EID: 14944351108     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000156276.87952.2c     Document Type: Review

References (72)

1. Kemper K, McLellan M, Highfield ES. Massage therapy and acupuncture for children with chronic pulmonary disease. Clin Pulmonary Med. 2004;in press.
2. Gyorik SA, Brutsche MH. Complementary and alternative medicine for bronchial asthma: is there new evidence? Curr Opin Pulmonary Med. 2004;10:37-43.
3. Shenfield G, Lim E, Allen H. Survey of the use of complementary medicines and therapies in children with asthma. J Paediatr Child Health. 2002;38:252-257.
4. Dinkevich E, Sass P, Pereira L, et al. Complementary and alternative medicine use by African-American and Caribbean-American children with asthma. Pediatr Res. 2003;53:188A.
5. Braganza S, Ozuah PO, Sharif I. The use of complementary therapies in inner-city asthmatic children. J Asthma. 2003;40:823-827.
6. Mazur LJ, De Ybarrondo L, Miller J, et al. Use of alternative and complementary therapies for pediatric asthma. Tex Med. 2001;97:64-68.
7. Davis PA, Gold EB, Hackman RM, et al. The use of complementary/ alternative medicine for the treatment of asthma in the United States. J Invest Allergol Clin Immunol. 1998;8:73-77.
8. Schwartz J, Weiss ST. The relationship of dietary fish intake to level of pulmonary function in the first National Health and Nutrition Survey (NHANES I). Eur Respir J. 1994;7:1821-1824.
9. Hodge L, Salome CM, Peat JK, et al. Consumption of oily fish and childhood asthma risk. Med J Aust. 1996;164:137-140.
10. Beckles Willson N, Elliott TM, Everard ML. Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database Syst Rev. 2002;(3):CD002201.
11. Nagakura T, Matsuda S, Shichijyo K, et al. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J. 2000;16:861-865.
12. Woods RK, Thien FC, Abramson MJ. Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst Rev. 2002;(3):CD001283.
13. Foran SE. Flood JG, Lewandrowski KB. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish? Arch Pathol Lab Med. 2003;127:1603-1605.
14. Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council; 1998.
15. Monteleone CA, Sherman AR. Nutrition and asthma. Arch Intern Med. 1997;157:23-34.
16. Gilliland FD, Berhane KT, Li YF, et al. Children's lung function and antioxidant vitamin, fruit, juice, and vegetable intake. Am J Epidemiol. 2003;158:576-584.
17. Cook DG, Carey IM, Whincup PH, et al. Effect of fresh fruit consumption on lung function and wheeze in children. Thorax. 1997;52:628-633.
18. Bielory L, Gandhi R. Asthma and vitamin C. Ann Allergy. 1994;73:89-96.
19. Schapowal A. Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. BMJ. 2002;324:144-146.
20. Thomet OA, Simon HU. Petasins in the treatment of allergic diseases: results of preclinical and clinical studies. Int Arch Allergy Immunol. 2002;129:108-112.
21. Danesch UC. Petasites hybridus (butterbur root) extract in the treatment of asthma: an open trial. Altern Med Rev. 2004;9:54-62.
22. Lee DK, Haggart K, Robb FM, et al. Butterbur, a herbal remedy, confers complementary anti-inflammatory activity in asthmatic patients receiving inhaled corticosteroids. Clin Exp Allergy. 2004;34:110-114.
23. Thiruvengadam KV, Haranath K, Sudarsan S, et al. Tylophora indica in bronchial asthma (a controlled comparison with a standard anti-asthmatic drug). J Indian Med Assoc. 1978;71:172-176.
24. Ammon HP, Safayhi H, Mack T, et al. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol. 1993;38:113-119.
25. Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998;3:511-514.
26. Schwartz J, Weiss ST. Caffeine intake and asthma symptoms. Ann Epidemiol. 1992;2:627-635.
27. Bara AI, Barley EA. Caffeine for asthma. Cochrane Database Syst Rev. 2001;(4):CD001112.
28. Vansal SS, Feller DR. Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes. Biochem Pharmacol. 1999;58:807-810.
29. Alanko K, Lahdensuo A. Comparison of salbutamol and ephedrine in oral bronchodilator combinations with theophylline and hydroxyzine: their effects on asthmatics. Ann Clin Res. 1977;9:287-291.
30. Caplin I, Haynes JT. A re-evaluation of ephedrine/theophylline combinations in the treatment of asthma. J Indiana State Med Assoc. 1978;71:492-495.
31. Falliers CJ, Cato AE, Harris JR. Controlled assessment of oral bronchodilators for asthmatic children. J Int Med Res. 1978;6:326-336.
32. McLaughlin ET, Bethea LH, Wittig HJ. Comparison of the bronchodilator effect of oral fenoterol and ephedrine in asthmatic children. Ann Allergy. 1982;49:191-195.
33. VanArsdel PP Jr, Schaffrin RM, Rosenblatt J, et al. Evaluation of oral fenoterol in chronic asthmatic patients. Chest. 1978;73(6 suppl):997-998.
34. Bent S, Tiedt TN, Odden MC, et al. The relative safety of ephedra compared with other herbal products. Ann Intern Med. 2003;138:468-471.
35. George M. The challenge of culturally competent health care: applications for asthma. Heart Lung. 2001;30:392-400.
36. Seamon K, Daly JW. Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J Biol Chem. 1981;256:9799-9801.
37. Seamon KB, Daly JW. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res. 1981;7:201-224.
38. Lichey I, Friedrich T, Priesnitz M, et al. Effect of forskolin on methacholine-induced bronchoconstriction in extrinsic asthmatics. Lancet. 1984;2:167.
39. Bauer K, Dietersdorfer F, Sertl K, et al. Pharmacodynamic effects of inhaled dry powder formulations of fenoterol and colforsin in asthma. Clin Pharmacol Ther. 1993;53:76-83.
40. Hibino N, Kawai A, Uchikawa S, et al. Cardiovascular effects of colforsin daropate hydrochloride for acute heart failure after open heart surgery. Kyobu Geka. 2001;54:1016-1019.
41. Mathew R, Altura BM. Magnesium and the lungs. Magnesium. 1988;7:173-187.
42. Mathew R, Altura BM. The role of magnesium in lung diseases: asthma, allergy and pulmonary hypertension. Magnes Trace Elem. 1991;10:220-228.
43. McLean RM. Magnesium and its therapeutic uses: a review. Am J Med. 1994;96:63-76.
44. Cairns CB, Kraft M. Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients. Acad Emerg Med. 1996;3:1093-1097.
45. Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. Lancet. 1994;344:357-362.
46. Dominguez LJ, Barbagallo M, Di Lorenzo G, et al. Bronchial reactivity and intracellular magnesium: a possible mechanism for the bronchodilating effects of magnesium in asthma. Clin Sci (Lond). 1998;95:137-142.
47. Hill J. Magnesium and airway reactivity. Clin Sci (Lond). 1998;95:111-112.
48. Harari M, Barzillai R, Shani J. Magnesium in the management of asthma: critical review of acute and chronic treatments, and Deutsches Medizinisches Zentrum's (DMZ's) clinical experience at the Dead Sea. J Asthma. 1998;35:525-536.
49. McNamara RM, Spivey WH, Skobeloff E, et al. Intravenous magnesium sulfate in the management of acute respiratory failure complicating asthma. Ann Emerg Med. 1989;18:197-199.
50. Silverman RA, Osborn H, Runge J, et al. IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial. Chest. 2002;122:489-497.
51. Green SM, Rothrock SG. Intravenous magnesium for acute asthma: failure to decrease emergency treatment duration or need for hospitalization. Ann Emerg Med. 1992;21:260-265.
52. Porter RS, Nester Braitman LE, et al. Intravenous magnesium is ineffective in adult asthma, a randomized trial. Eur J Emerg Med. 2001;8:9-15.
53. Tiffany BR, Berk WA, Todd IK, White SR. Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations. Chest. 1993;104:831-834.
54. Rowe BH, Bretzlaff JA, Bourdon C, et al. Intravenous magnesium sulfate treatment for acute asthma in the emergency department: a systematic review of the literature. Cochrane Database Syst Rev. 2000;36:181-190.
55. Rodrigo G, Rodrigo C, Burschtin O. Efficacy of magnesium sulfate in acute adult asthma: a meta-analysis of randomized trials. Am J Emerg Med. 2000;18:216-221.
56. Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med. 2000;154:979-983.
57. Scarfone RJ, Loiselle JM, Joffe MD, et al. A randomized trial of magnesium in the emergency department treatment of children with asthma. Ann Emerg Med. 2000;36:572-578.
58. Markovitz B. Does magnesium sulphate have a role in the management of paediatric status asthmaticus? Arch Dis Child. 2002;86:381-382.
59. Gurkan F, Haspolat K, Bosnak M, et al. Intravenous magnesium sulphate in the management of moderate to severe acute asthmatic children nonresponding to conventional therapy. Eur J Emerg Med. 1999;6:201-205.
60. Nannini LJ Jr, Hofer D. Effect of inhaled magnesium sulfate on sodium metabisulfite-induced bronchoconstriction in asthma. Chest. 1997;111: 858-861.
61. Bucca C, Rolla G. Nebulised magnesium in asthma: the right solution for an old remedy? Lancet. 2003;361:2095-2096.
62. Hughes R, Goldkorn A, Masoli M, et al. Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial. Lancet 2003;361:2114-2117.
63. Fogarty A, Lewis SA, Scrivener SL, et al. Oral magnesium and vitamin C supplements in asthma: a parallel group randomized placebo-controlled trial. Clin Exp Allergy. 2003;33:1355-1359.
64. Brinckmann J, Sigwart H, van Houten Taylor L. Safety and efficacy of a traditional herbal medicine (Throat Coat) in symptomatic temporary relief of pain in patients with acute pharyngitis: a multicenter, prospective, randomized, double-blinded, placebo-controlled study. J Altern Complement Med 2003;9:285-298.
65. Hirono I, Mori H, Culvenor CC. Carcinogenic activity of coltsfoot, Tussilago farfara 1. Gann. 1976;67:125-129.
66. Sperl W, Stuppner H, Gassner I, et al. Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea. Eur J Pediatr. 1995;154:112-116.
67. Fleming T. PDR for Herbal Medicines. Montvale, NJ: Medical Economics Company, Inc; 1998.
68. 67a. Weil A. Natural health, natural medicine: the complete guide to wellness and self-care for optimum health. Houghton-Mifflin, 2004.
69. Turker AU, Camper ND. Biological activity of common mullein, a medicinal plant. J Ethnopharmacol. 2002;82:117-125.
70. Reznik M, Ozuah PO, Franco K, et al. Use of complementary therapy by adolescents with asthma. Arch Pediatr Adolesc Med. 2002;156:1042-1044.
71. Ziment I. Non-Western herbal medicines. J Am Med Dir Assoc. 2000;1:137-141.
72. Bielory L, Chiaramonte L, Ehrlich P, et al. Alternative treatment for allergy and asthma. J Asthma. 2003;40(suppl):47-53.